Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Bupivacaine for Post-Operative Pain in Endodontic Treatment
NCT05338671Phase 4Completed
- Sponsor
- University of Washington
- Start
- Sep 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain and irreversible pulpitis comparing Lidocaine Arm with Bupivacaine Arm (2 arms). Primary endpoints: Visual Analog Scale at 6 Hours, Visual Analog Scale at 12 Hours and 3 more. Started Sep 2021; status: completed.
02
Drugs
lidocainebupivacaine
03
Conditions
postoperative painirreversible pulpitis
Beyond the preview
Go deeper on NCT05338671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05338671.